Emergent BioSolutions Finalizes Sale of Travel Health
GAITHERSBURG, Md., May 15, 2023 (GLOBE NEWSWIRE) — Emergent BioSolutions (NYSE: EBS) today announced it has completed the sale of its travel health business to Bavarian Nordic (OMX: BAVA). At closing Emergent received $270 million, subject to customary closing adjustments, and may receive up to an additional $110 million in potential future milestone payments. With … [Read more…]